Depression Treatment in Pakistan: What Works, What Does Not, and When Therapy Is Not Enough

Depression-Treatment-in-Pakistan

Author: Dr. Obaid Ullah Khan, Consultant Psychiatrist, Federal City Rehab Clinic. Specialist in psychiatric assessment and treatment of depression, anxiety disorders, bipolar disorder, schizophrenia, PTSD, OCD, and dual diagnosis presentations.

Depression is the most common mental health condition in Pakistan. It is also one of the most under-treated. Millions of people are living with a condition that responds to treatment, suffering in ways they do not have to suffer, because they do not know what treatment looks like, where to find it, or whether it will actually help.

The World Health Organization estimates that depression affects 280 million people globally and is a leading cause of disability worldwide. In Pakistan, research published in JCPSP estimates that between 34 and 66 percent of patients presenting to general practitioners in Pakistan have significant depressive symptoms, yet the vast majority never receive appropriate psychiatric or psychological treatment.

This article is for people in Pakistan who are struggling with depression, for their families, and for those who have tried treatment before and found it did not work. It covers what depression actually is, what treatment approaches have genuine evidence behind them, what to do when therapy alone is not sufficient, and how FCRC approaches depression treatment as part of its comprehensive psychiatric and rehabilitation programme.

What Depression Actually Is

Depression is not sadness. Everyone feels sad. Depression is a persistent alteration in mood, cognition, and physical function that goes beyond ordinary emotional responses to life events. It is a medical condition with neurobiological roots involving dysregulation of serotonin, norepinephrine, dopamine, and the hypothalamic-pituitary-adrenal axis.

The clinical criteria for major depressive disorder, per the DSM-5, require at least five of the following symptoms present for two weeks or more, with at least one being depressed mood or loss of interest:

  • Depressed mood most of the day, nearly every day
  • Markedly diminished interest or pleasure in all or most activities
  • Significant weight loss or gain, or changes in appetite
  • Insomnia or sleeping excessively
  • Psychomotor agitation or slowing observable to others
  • Fatigue or loss of energy nearly every day
  • Feelings of worthlessness or excessive or inappropriate guilt
  • Difficulty thinking, concentrating, or making decisions
  • Recurrent thoughts of death, suicidal ideation, or a suicide attempt

Depression exists on a spectrum. Mild depression may respond to psychological therapy alone. Moderate depression typically requires a combination of therapy and medication. Severe depression, particularly with psychotic features, melancholia, or active suicidal ideation, requires psychiatric intervention and may require inpatient care.

Why Depression Goes Untreated in Pakistan

A landmark PubMed study on barriers to psychological help-seeking in Pakistan identified the dominant barriers as religious fatalism, personal shame, social defamation, carelessness for mental disorders, and fear of treatment. These translate into specific patterns that delay treatment by months and years.

Depression is misread as weakness or laziness

In Pakistan’s cultural context, a person with depression is frequently told to pray more, try harder, think positively, or focus on how much they have to be grateful for. These responses are not cruel by intent. They reflect a sincere belief that depression is a spiritual or motivational problem rather than a medical one. The effect is to make the person with depression feel additionally guilty for not being able to recover through willpower.

It is attributed to external circumstances

Families often attribute depression to a specific stressor and expect it to resolve when the stressor does. While life events can trigger depressive episodes, clinical depression is a neurobiological condition that persists beyond its triggers and requires treatment in its own right.

Psychiatric treatment carries stigma

Seeing a psychiatrist in Pakistan carries enormous social stigma. The fear of being labelled pagal, of having the family branded as having mental illness, and of the consequences for marriage or employment keeps many people from ever seeking the specialist help they need.

What Works: Evidence-Based Treatments for Depression

Psychotherapy

Cognitive Behavioural Therapy (CBT) has the strongest evidence base of any psychological treatment for depression. It works by identifying and restructuring the distorted thought patterns that maintain depressive states, building behavioural activation, and teaching practical skills for managing low mood. For mild to moderate depression, CBT alone can produce full remission. For more severe depression, it is most effective in combination with medication.

Interpersonal Therapy (IPT) addresses the relationship context of depression and is particularly effective where depression is linked to grief, relationship conflict, role transitions, or social isolation. NICE guidelines for depression recommend both CBT and IPT as first-line psychological treatments.

Psychodynamic psychotherapy and trauma-focused approaches are indicated where depression is rooted in unresolved trauma or long-standing psychological conflicts. At FCRC, our doctoral-level psychologists are trained across the full range of evidence-based modalities and match the therapeutic approach to the specific presentation of each patient.

Medication

Antidepressant medication is effective and, for moderate to severe depression, is considered a first-line treatment in combination with psychotherapy. The commonly held fears about antidepressants in Pakistan, that they are addictive, that they change the personality, or that they need to be taken forever, are not supported by clinical evidence for most patients when prescribed and monitored appropriately.

The selection of medication is a clinical decision made by a consultant psychiatrist based on the severity and subtype of depression, the patient’s medical history, other medications, and specific symptom profile. At FCRC, prescribing is managed entirely by our consultant psychiatrists and reviewed regularly throughout the patient’s programme.

For treatment-resistant depression, newer approaches including augmentation strategies are available and managed by our psychiatric team where indicated.

Combined treatment

The strongest evidence for moderate to severe depression supports the combination of psychotherapy and medication over either alone. This is the standard approach at FCRC: every patient with significant depression receives both psychiatric medication management and regular individual therapy.

When Therapy Is Not Enough: The Need for Inpatient Psychiatric Care

The following situations require immediate psychiatric assessment and may require inpatient care. If you or someone you love is in this situation, please call FCRC or seek emergency help immediately.

 

  • Active suicidal ideation with plan or intent: A person expressing a wish to die with a specific plan is in immediate clinical danger and requires inpatient management.
  • Severe depression with psychotic features: Depression accompanied by hallucinations, delusions, or complete loss of contact with reality requires combined antidepressant and antipsychotic treatment in a supervised environment.
  • Inability to function in daily life: Where depression has progressed to the point that the person cannot eat, cannot maintain basic hygiene, or cannot be safely managed at home, inpatient care provides the structure and safety that outpatient treatment cannot.
  • Failure to respond to outpatient treatment: Multiple failed outpatient treatment attempts, non-compliance with medication, or persistent severe symptoms despite appropriate treatment indicate the need for a more intensive, supervised approach.
  • Co-occurring addiction: Where depression co-occurs with substance dependency, integrated inpatient treatment addressing both simultaneously produces far better outcomes than sequential treatment or outpatient management of either alone.

Depression and Addiction: The Dual Diagnosis Reality

A significant proportion of FCRC’s patients present with both depression and substance use disorder. The relationship is bidirectional: depression increases vulnerability to substance use as a form of self-medication, and chronic substance use produces or worsens depressive disorders. Research from PubMed on dual diagnosis in Pakistan confirms the high co-occurrence of mood disorders and substance use in Pakistani treatment populations.

Treating the addiction without treating the depression, or the depression without addressing the addiction, leaves the core vulnerability unresolved. FCRC’s dual diagnosis programme treats both conditions simultaneously in an integrated clinical plan, which is the standard of care for co-occurring disorders and the approach that produces the best long-term outcomes.

Depression Treatment at FCRC

FCRC provides comprehensive depression treatment through our mental health and psychiatric services, led by board-certified consultant psychiatrists with specialist training in mood disorders.

What the assessment involves

Every patient presenting with depression at FCRC receives a thorough psychiatric assessment establishing the severity and subtype of depression, any co-occurring conditions including anxiety, trauma, or substance use, the patient’s medical history and current medications, family psychiatric history, and psychosocial stressors. This assessment is the foundation for a treatment plan that is genuinely personalised rather than generic.

The treatment programme

Inpatient treatment for depression at FCRC combines daily individual therapy with our clinical psychologists, psychiatric medication management reviewed and adjusted throughout the programme, group therapy, and structured daily activity. For patients with co-occurring addiction, the full dual diagnosis programme runs alongside the psychiatric treatment.

Aftercare

Depression has a significant relapse rate without appropriate maintenance treatment. FCRC’s aftercare programme includes a clear plan for ongoing medication management, outpatient therapy sessions, and a framework for early identification and management of relapse indicators.

Frequently Asked Questions

Are antidepressants addictive?

Standard antidepressants, including SSRIs and SNRIs, are not addictive in the clinical sense. They do not produce tolerance requiring dose escalation, craving, or compulsive drug-seeking behaviour. Some require gradual tapering when discontinued to avoid discontinuation symptoms, which should be managed with medical guidance. The decision to take or discontinue antidepressants should always be made with your prescribing psychiatrist.

This varies significantly depending on severity, duration, and the presence of co-occurring conditions. A first episode of moderate depression may respond to four to six months of combined therapy and medication. Recurrent or severe depression typically requires longer treatment and ongoing maintenance. Your psychiatrist will discuss the expected timeline based on your specific presentation after the initial assessment.

For mild depression, psychotherapy alone, particularly CBT, is often sufficient. For moderate to severe depression, the evidence strongly supports combined treatment. The decision about medication is always made in consultation with the patient and is based on clinical presentation rather than a blanket policy.

Completely. No information about your assessment, diagnosis, or treatment is shared with any employer, institution, family member, or third party without your explicit written consent.

Depression is treatable. The millions of people in Pakistan living with untreated depression are not beyond help. They are underserved. If you or someone you love is struggling, please reach out.

Our team is available around the clock for a free and confidential consultation. Call us at 0330 1454321 or visit the contact us page.

Conclusion

Dual diagnosis is not an exotic or unusual presentation. It is the clinical norm for serious addiction in Pakistan, made more severe by the country’s significant mental health treatment gap. Patients with addiction whose underlying psychiatric conditions remain unrecognised receive incomplete treatment, and the relapse that often follows is not random failure but predictable clinical consequence.

What changes outcomes is integrated treatment. Comprehensive psychiatric assessment that explicitly looks for co-occurring conditions. Coordinated clinical care that addresses both the addiction and the mental illness within the same programme. Evidence-based therapy that targets both dimensions. Medication management where indicated for the psychiatric condition, alongside addiction-focused work. Aftercare that accounts for the management of both conditions over the long term.

Federal City Rehab Clinic was designed to provide exactly this kind of integrated treatment. For families whose previous treatment attempts have not produced lasting recovery, and for families starting this process for the first time who want to ensure they are getting genuinely comprehensive care, FCRC’s clinical model is built around the reality of how serious addiction actually presents in Pakistan.

If you would like to begin a confidential conversation about your family’s situation, reach out to our admissions team through our contact page. We are available 24 hours a day, every day of the year, with no pressure, no judgement, and complete privacy.

Picture of Dr. Obaid Ullah Khan

Dr. Obaid Ullah Khan

Dr. Obaid Ullah Khan is the Consultant Psychiatrist at Federal City Rehab Clinic, providing comprehensive psychiatric assessment and treatment for the full spectrum of mental health conditions including depression, anxiety disorders, bipolar disorder, schizophrenia, PTSD, OCD, and dual diagnosis presentations. He is responsible for psychiatric medication management, complex diagnostic work, and the integrated treatment of patients with co-occurring addiction and mental health conditions. His clinical approach combines pharmacological expertise with a commitment to long-term, sustainable recovery.